FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912954134> ?p ?o ?g. }

• W2912954134 endingPage "1122" @default.
• W2912954134 startingPage "1113" @default.
• W2912954134 abstract "Background and Aims Previous studies have shown low rates of diagnosis and treatment of hepatitis C virus (HCV) infection in people who inject drugs (PWID). Our aims were to test the effect of a complex intervention [Hepatitis C Awareness Through to Treatment (HepCATT)] in drug and alcohol clinics—primarily, on engagement of HCV-positive PWID with therapy and, secondarily, on testing for HCV, referral to hepatology services and start of HCV treatment. Design and setting A non-randomized pilot study in three specialist addiction clinics in England comparing an intervention year (starting between September 2015 and February 2016) with a baseline year (2014), together with three control clinics. Participants Analysis included all attendees at the intervention and control specialist addiction clinics identified as PWID. Intervention The intervention comprised the placement of a half-time facilitator in each clinic for 12 months with the brief to increase diagnosis of HCV infection within clients at those services and the engagement of diagnosed individuals with an appropriate care pathway. The facilitator undertook various activities, which could include training of key workers, direct interaction with clients, streamlining and support for hepatology appointments and introduction of dried blood-spot testing. Measurements For each clinic and period, we obtained the total number of clients and, as relevant, their status as PWID, tested for HCV, known HCV-positive, engaged with HCV therapy or treated. Findings Compared with baseline, there was strong evidence that engagement with HCV therapy in the intervention year increased (P < 0.001) more in the HepCATT centres than controls, up +31 percentage points [95% confidence interval (CI) = 19–43] versus −12 (CI = –31 to +6) and odds ratio (OR) = 9.99 (CI = 4.42–22.6) versus 0.35 (CI = 0.08–1.56). HepCATT centres also had greater increases in HCV testing (OR = 3.06 versus 0.78, P < 0.001), referral to hepatology (OR = 9.60 versus 0.56, P < 0.001) and treatment initiation (OR = 9.5 versus 0.74, P < 0.001). Conclusions Introducing a half-time facilitator into drug and alcohol clinics in England increased engagement of HCV-positive people who inject drugs with hepatitis C virus care pathways, with increased uptake also of testing, referral to hepatology and initiation of treatment." @default.
• W2912954134 created "2019-02-21" @default.
• W2912954134 creator A5000073653 @default.
• W2912954134 creator A5002183213 @default.
• W2912954134 creator A5009320826 @default.
• W2912954134 creator A5013768166 @default.
• W2912954134 creator A5022647467 @default.
• W2912954134 creator A5024080258 @default.
• W2912954134 creator A5028094698 @default.
• W2912954134 creator A5032359521 @default.
• W2912954134 creator A5032776680 @default.
• W2912954134 creator A5039127347 @default.
• W2912954134 creator A5039138340 @default.
• W2912954134 creator A5050067860 @default.
• W2912954134 creator A5054589264 @default.
• W2912954134 creator A5056406094 @default.
• W2912954134 creator A5064251615 @default.
• W2912954134 creator A5064304141 @default.
• W2912954134 creator A5064925118 @default.
• W2912954134 creator A5064954217 @default.
• W2912954134 creator A5065033982 @default.
• W2912954134 creator A5068697843 @default.
• W2912954134 creator A5077131274 @default.
• W2912954134 creator A5080026732 @default.
• W2912954134 creator A5089883020 @default.
• W2912954134 creator A5090100292 @default.
• W2912954134 date "2019-03-12" @default.
• W2912954134 modified "2023-10-05" @default.
• W2912954134 title "The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus‐infected people who inject drugs in England" @default.
• W2912954134 cites W1135249552 @default.
• W2912954134 cites W1661944539 @default.
• W2912954134 cites W1746911508 @default.
• W2912954134 cites W1912645906 @default.
• W2912954134 cites W1964431848 @default.
• W2912954134 cites W1965388675 @default.
• W2912954134 cites W1970767885 @default.
• W2912954134 cites W1979129700 @default.
• W2912954134 cites W2006155245 @default.
• W2912954134 cites W2012583795 @default.
• W2912954134 cites W2037763899 @default.
• W2912954134 cites W2077095964 @default.
• W2912954134 cites W2089106363 @default.
• W2912954134 cites W2102258338 @default.
• W2912954134 cites W2115120907 @default.
• W2912954134 cites W2142011497 @default.
• W2912954134 cites W2143484488 @default.
• W2912954134 cites W2146117001 @default.
• W2912954134 cites W2147336517 @default.
• W2912954134 cites W2153211140 @default.
• W2912954134 cites W2281722587 @default.
• W2912954134 cites W2301185065 @default.
• W2912954134 cites W2334215547 @default.
• W2912954134 cites W2516204058 @default.
• W2912954134 cites W2547268867 @default.
• W2912954134 cites W2792962057 @default.
• W2912954134 doi "https://doi.org/10.1111/add.14569" @default.
• W2912954134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30694582" @default.
• W2912954134 hasPublicationYear "2019" @default.
• W2912954134 type Work @default.
• W2912954134 sameAs 2912954134 @default.
• W2912954134 citedByCount "28" @default.
• W2912954134 countsByYear W29129541342019 @default.
• W2912954134 countsByYear W29129541342020 @default.
• W2912954134 countsByYear W29129541342021 @default.
• W2912954134 countsByYear W29129541342022 @default.
• W2912954134 countsByYear W29129541342023 @default.
• W2912954134 crossrefType "journal-article" @default.
• W2912954134 hasAuthorship W2912954134A5000073653 @default.
• W2912954134 hasAuthorship W2912954134A5002183213 @default.
• W2912954134 hasAuthorship W2912954134A5009320826 @default.
• W2912954134 hasAuthorship W2912954134A5013768166 @default.
• W2912954134 hasAuthorship W2912954134A5022647467 @default.
• W2912954134 hasAuthorship W2912954134A5024080258 @default.
• W2912954134 hasAuthorship W2912954134A5028094698 @default.
• W2912954134 hasAuthorship W2912954134A5032359521 @default.
• W2912954134 hasAuthorship W2912954134A5032776680 @default.
• W2912954134 hasAuthorship W2912954134A5039127347 @default.
• W2912954134 hasAuthorship W2912954134A5039138340 @default.
• W2912954134 hasAuthorship W2912954134A5050067860 @default.
• W2912954134 hasAuthorship W2912954134A5054589264 @default.
• W2912954134 hasAuthorship W2912954134A5056406094 @default.
• W2912954134 hasAuthorship W2912954134A5064251615 @default.
• W2912954134 hasAuthorship W2912954134A5064304141 @default.
• W2912954134 hasAuthorship W2912954134A5064925118 @default.
• W2912954134 hasAuthorship W2912954134A5064954217 @default.
• W2912954134 hasAuthorship W2912954134A5065033982 @default.
• W2912954134 hasAuthorship W2912954134A5068697843 @default.
• W2912954134 hasAuthorship W2912954134A5077131274 @default.
• W2912954134 hasAuthorship W2912954134A5080026732 @default.
• W2912954134 hasAuthorship W2912954134A5089883020 @default.
• W2912954134 hasAuthorship W2912954134A5090100292 @default.
• W2912954134 hasBestOaLocation W29129541342 @default.
• W2912954134 hasConcept C118552586 @default.
• W2912954134 hasConcept C126322002 @default.
• W2912954134 hasConcept C168563851 @default.
• W2912954134 hasConcept C17744445 @default.
• W2912954134 hasConcept C199539241 @default.
• W2912954134 hasConcept C203014093 @default.

• next